EUVIMEDEUVIMED entdecken
Crossref

Tacrolimus 0.1% Ophthalmic Suspension: Corneal and Intraocular Penetration Study

Maxime Quirke iD, Fabien Lamoureux, Christophe Arnoult, Gladys Gress, Ariella Ganem, Théophile Charpentier, Marc Muraine, Julie Gueudry iD

Journal of Ocular Pharmacology and Therapeutics · 2025

DOI: 10.1089/jop.2024.0165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2025. Verfasst von Maxime Quirke und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, CHU Charles Nicolle, Rouen, France. Hauptthemen laut MEDLINE: Tacrolimus, Immunosuppressive Agents, Cornea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusImmunosuppressive AgentsCorneaAnimalsRabbitsOphthalmic SolutionsAdministration, OphthalmicMaleSuspensionsChromatography, High Pressure Liquid

Stichwörter der Autor:innen

corneadrug deliverydrug penetrationkeratoplastypharmacokineticstacrolimus

Substanzen

TacrolimusImmunosuppressive AgentsOphthalmic SolutionsSuspensions

Autor:innen und Institutionen

  • Department of Ophthalmology, CHU Charles Nicolle, Rouen, France.
  • Department of Pharmacology, CHU Charles Nicolle, Rouen, France.
  • Rouen Medical Training Center, CHU Charles Nicolle, Rouen, France.
  • EA 7510 Epidemio-surveillance and circulation of parasites in the environment, Faculty of Medicine and Pharmacy, Rouen University, Rouen, France.

ORCID-Profile: Maxime Quirke, Julie Gueudry

Zitieren

APA

Quirke, M., Lamoureux, F., Arnoult, C., Gress, G., Ganem, A., Charpentier, T., Muraine, M., & Gueudry, J. (2025). Tacrolimus 0.1% Ophthalmic Suspension: Corneal and Intraocular Penetration Study. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2024.0165

Vancouver

Quirke M, Lamoureux F, Arnoult C, Gress G, Ganem A, Charpentier T, et al. Tacrolimus 0.1% Ophthalmic Suspension: Corneal and Intraocular Penetration Study. Journal of Ocular Pharmacology and Therapeutics. 2025. doi:10.1089/jop.2024.0165

BibTeX
@article{Quirke2025,
  author = {Quirke, Maxime and Lamoureux, Fabien and Arnoult, Christophe and Gress, Gladys and Ganem, Ariella and Charpentier, Théophile and Muraine, Marc and Gueudry, Julie},
  title = {Tacrolimus 0.1% Ophthalmic Suspension: Corneal and Intraocular Penetration Study},
  journal = {Journal of Ocular Pharmacology and Therapeutics},
  year = {2025},
  doi = {10.1089/jop.2024.0165}
}
Kostenlos starten →